Prestige Biologics Co., Ltd. (KOSDAQ:334970)
South Korea · Delayed Price · Currency is KRW 1,408.00
+2.00 (0.14%)
At close: Oct 8, 2026
Prestige Biologics Cash Flow Statement
Financials in millions KRW. Fiscal year is July - June.
Millions KRW. Fiscal year is Jul - Jun.
Operating Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Dec '22 Dec 31, 2022 |
Net Income | -51,220 | -27,469 | -29,374 | -39,442 | -49,718 |
Depreciation & Amortization | 16,865 | 13,083 | 11,231 | 8,414 | 7,938 |
Loss (Gain) From Sale of Assets | 1.74 | 6.86 | -90.87 | -67.29 | -66.42 |
Asset Writedown & Restructuring Costs | 5,236 | - | - | 646.03 | 646.03 |
Stock-Based Compensation | - | - | -54.88 | 222.14 | 294.5 |
Other Operating Activities | 4,183 | -6,728 | -11,354 | 12,860 | 14,940 |
Change in Accounts Receivable | -2,704 | -51.97 | 674.2 | -1,063 | 1,175 |
Change in Inventory | -4,783 | -4,713 | 7,081 | -11,351 | -13,772 |
Change in Accounts Payable | -493.59 | 4,189 | 2,461 | 292.7 | -2,317 |
Change in Unearned Revenue | -142.26 | -309.87 | -5.22 | -663.92 | 147.48 |
Change in Other Net Operating Assets | 36,260 | 3,685 | 11,087 | 5,323 | 6,608 |
Operating Cash Flow | 3,203 | -18,308 | -8,345 | -24,830 | -34,124 |
Operating Cash Flow Growth | - | - | - | - | - |
Investing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Dec '22 Dec 31, 2022 |
Capital Expenditures | -2,292 | -5,226 | -8,522 | -35,435 | -84,642 |
Sale of Property, Plant & Equipment | 65.05 | 72.88 | 54 | 1,081 | 1,105 |
Sale (Purchase) of Intangibles | -847.04 | -430.06 | 350.02 | -107.47 | -147.41 |
Other Investing Activities | 64 | 24.82 | 191.11 | -19.29 | 19.23 |
Investing Cash Flow | -3,010 | -5,558 | -7,927 | -34,481 | -83,665 |
Financing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Dec '22 Dec 31, 2022 |
Long-Term Debt Issued | 15,000 | - | - | - | 96,172 |
Total Debt Issued | 15,000 | - | - | 56,500 | 96,172 |
Short-Term Debt Repaid | -9,800 | -94,964 | - | - | - |
Long-Term Debt Repaid | -63.65 | -67.97 | -913.51 | - | -59,912 |
Total Debt Repaid | -9,864 | -95,031 | -913.51 | -60,035 | -59,912 |
Net Debt Issued (Repaid) | 5,136 | -95,031 | -913.51 | -3,535 | 36,260 |
Issuance of Common Stock | - | 91,042 | 1,310 | 59,867 | 60,246 |
Other Financing Activities | - | -51.19 | -52.34 | -42.75 | -42.75 |
Financing Cash Flow | 5,136 | -4,041 | 344.5 | 56,289 | 96,463 |
Net Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Dec '22 Dec 31, 2022 |
Foreign Exchange Rate Adjustments | 31.71 | -18.82 | - | -472.96 | -65.68 |
Miscellaneous Cash Flow Adjustments | - | - | -0 | -0 | -0 |
Net Cash Flow | 5,361 | -27,926 | -15,928 | -3,494 | -21,392 |
Free Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Dec '22 Dec 31, 2022 |
Free Cash Flow | 910.95 | -23,534 | -16,867 | -60,265 | -118,767 |
Free Cash Flow Growth | - | - | - | - | - |
Free Cash Flow Margin | 3.42% | -187.77% | -777.63% | -3451.94% | -763002.69% |
Free Cash Flow Per Share | 11.72 | -319.56 | -275.34 | -1027.35 | -2295.00 |
Levered Free Cash Flow | 9,246 | -33,288 | -27,812 | - | -98,250 |
Unlevered Free Cash Flow | 13,569 | -27,829 | -20,456 | - | -95,795 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Dec '22 Dec 31, 2022 |
Cash Interest Paid | 1,906 | 4,686 | 3,355 | 4,831 | 4,764 |
Cash Income Tax Paid | - | - | - | 11.84 | -40.39 |
Change in Working Capital | 28,137 | 2,799 | 21,297 | -7,462 | -8,158 |